This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
Vascular inflammation creates a variable clinical picture
Equine arteritis virus can affect blood vessels and produce swelling as well as respiratory and systemic signs. Fever, dullness, reduced appetite, conjunctivitis and limb or genital edema may occur. Some infections remain unapparent, so an absence of obvious respiratory illness does not clear a breeding animal.
The outcome also depends on the patient. A recovering adult, an infected pregnant mare and a young foal with severe disease have different prognostic concerns. The name arteritis should not lead to treating every swollen limb or abortion as EVA; other infections and noninfectious causes require investigation.
Source: Equine viral arteritis; Equine viral arteritis.
Respiratory and reproductive routes can connect different groups
During acute infection, respiratory exposure can spread virus among horses. Semen from a shedding stallion can introduce infection through natural breeding or artificial insemination. A breeding-associated introduction can therefore become relevant to horses that were never intended for reproduction.
Stop movement and breeding pending veterinary advice when EVA is suspected. Keep affected horses away from pregnant mares and other susceptible contacts. Abortion material and contaminated equipment need professional biosecurity management; owners should avoid unnecessary handling and ask how the mare and foal or fetus will be assessed safely.
Source: Equine viral arteritis infectious disease guidelines; Equine viral arteritis.
A clinically recovered stallion may still shed virus in semen
Persistent carriage is especially important in breeding stallions. A stallion can look fit and fertile while semen remains infectious. The long-term carrier state differs from the relatively short clinical illness experienced by many adults.
A positive antibody test does not by itself establish that a stallion is a shedder. It can reflect natural exposure or vaccination. Veterinary testing and the prior vaccine history determine whether further evaluation of semen shedding is needed. Do not arrange diagnostic matings independently or assume an old antibody result certifies current breeding safety.
Source: Recommendations for transported semen as it relates to EVA; Equine viral arteritis vaccination guidelines.
Testing should match the clinical or breeding question
An acute outbreak investigation asks whether current illness, abortion or neonatal disease is associated with EAV. A breeding examination may instead ask whether a healthy stallion is a semen shedder. Those questions require different laboratory evidence and cannot be answered by a generic health certificate alone.
The veterinarian coordinates appropriate testing and official notifications. Vaccination history is unusually relevant because routine antibody tests do not distinguish vaccine response from natural infection. In a first-time vaccine candidate, a properly established pre-vaccination status can prevent later uncertainty about infection or export eligibility.
Source: Equine viral arteritis; Equine viral arteritis vaccination guidelines; Recommendations for transported semen as it relates to EVA.
Supportive care and realistic prognosis depend on age and severity
No specific antiviral cure is established. Rest, appropriate nursing and veterinary symptom control are often sufficient for adults, while more seriously affected patients need additional support. Prolonged fever and substantial scrotal swelling can temporarily affect a stallion’s fertility.
Severe disease in young foals can have a grave outlook, and abortion has consequences beyond the mare’s short-term recovery. Clinical recovery does not eliminate a persistent carrier state. Discuss the separate goals of helping the sick horse, protecting pregnancies and managing any future breeding risk rather than assume one successful treatment addresses all three.
Source: Equine viral arteritis; Equine viral arteritis.
Vaccination works best within a planned breeding strategy
Risk-based vaccination can protect susceptible horses and help prevent carrier-state development in stallions. It is not a treatment to clear an already established carrier. Product suitability, pregnancy status and regional permission requirements need veterinary review. The timing of protection and post-vaccination separation should follow the current applicable plan.
Carrier stallions may be managed within controlled breeding programs using appropriately protected mares and transparent shedding information. This requires specialist advice and compliance with current rules. Transported semen must not be assumed safe because it is chilled or frozen. Before export, check the destination’s actual requirements, since a vaccine-induced positive antibody result can affect entry conditions.
Source: Equine viral arteritis vaccination guidelines; Recommendations for transported semen as it relates to EVA; Equine viral arteritis; Equine viral arteritis infectious disease guidelines.
Practical questions
Does a positive antibody result mean a stallion is shedding?
No. Antibodies can reflect vaccination or natural exposure; shedding requires the appropriate further assessment.
Can EVA affect horses that are never bred?
Yes. Acute respiratory transmission can spread it among nonbreeding horses.
Can vaccination cure a carrier stallion?
No. It is a preventive tool and does not establish elimination of persistent semen shedding.
Related animal-health reading
Cite this reference
LivestockDefense. “Equine viral arteritis: respiratory spread, abortion and carrier stallions.” Updated 2026-11-02. https://livestockdefense.com/threats/equine-viral-arteritis/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- USDA APHIS: Equine viral arteritis
Source update: 2026-06-10. Most recent check: 2026-11-02.
Respiratory/reproductive disease, stallion carriage and current official vaccination oversight.
- Merck Veterinary Manual: Equine viral arteritis
Source update: Not provided. Most recent check: 2026-11-02.
Adult recovery versus foal/abortion severity, supportive care and diagnostic context; no test sampling or pathogen handling.
- AAEP: Equine viral arteritis infectious disease guidelines
Source update: 2023. Most recent check: 2026-11-02.
Carrier-stallion management and outbreak prevention; no test breeding or pathogen procedures.
- AAEP: Equine viral arteritis vaccination guidelines
Source update: Not provided. Most recent check: 2026-11-02.
Risk-based vaccination, antibody interpretation, pre-vaccine testing and pregnant-mare restrictions; no schedule or dose prescription.
- AAEP: Recommendations for transported semen as it relates to EVA
Source update: 2024. Most recent check: 2026-11-02.
Current specialist distinction between seropositivity and shedding, owner disclosure and breeding precautions; excludes test breeding, collection or testing procedures.
